| 1 |
Vincent JL. Current sepsis therapeutics[J]. EBioMedicine, 2022 (86): 104318.
|
| 2 |
Lakbar I, Munoz M, Pauly V, et al. Septic shock: incidence, mortality and hospital readmission rates in French intensive care units from 2014 to 2018[J]. Anaesth Crit Care Pain Med, 2022, 41 (3): 101082.
|
| 3 |
Lakbar I, Einav S, Lalevée N, et al. Interactions between gender and sepsis-implications for the future[J]. Microorganisms, 2023, 11 (3): 746.
|
| 4 |
陈敏，袁佳辉，郭冬阳，等. CXC趋化因子配体12/CXC趋化因子受体4轴在脓毒症中的研究进展[J/CD].中华危重症医学杂志（电子版），2020，13（3）：225-228.
|
| 5 |
Zaloga GP. Narrative review of n-3 polyunsaturated fatty acid supplementation upon immune functions, resolution molecules and lipid peroxidation[J]. Nutrients, 2021, 13 (2): 662.
|
| 6 |
Xu B, Xu Z, Xu D, et al. Effect of n-3 polyunsaturated fatty acids on ischemic heart disease and cardiometabolic risk factors: a two-sample Mendelian randomization study[J]. BMC Cardiovasc Disord, 2021, 21 (1): 532.
|
| 7 |
Yan CH, Rathor A, Krook K, et al. Effect of omega-3 supplementation in patients with smell dysfunction following endoscopic sellar and parasellar tumor resection: a multicenter prospective randomized controlled trial[J]. Neurosurgery, 2020, 87 (2): E91-E98.
|
| 8 |
Ying Q Croyal M, Chan DC, et al. Effect of omega-3 fatty acid supplementation on the postprandial metabolism of apolipoprotein (a) in familial hypercholesterolemia[J]. J Atheroscler Thromb, 2023, 30 (3): 274-286.
|
| 9 |
中华医学会肠外肠内营养学分会.鱼油脂肪乳剂临床应用中国专家共识（2022版）[J].中华消化外科杂志，2022，21（10）：1313-1325.
|
| 10 |
Yokote K, Niwa K, Hakoda T, et al. Short-term efficacy (at 12 weeks) and long-term safety (up to 52 weeks) of omega-3 free fatty acids (AZD0585) for the treatment of Japanese patients with dyslipidemia-a randomized, double-blind, placebo-controlled, phase III study[J]. Circ J, 2020, 84 (6): 994-1003.
|
| 11 |
Yuan M, Zhang Y, Hua T, et al. Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: a randomized, controlled trial[J]. Clin Nutr, 2021, 40 (2): 445-459.
|
| 12 |
Pontes-Arruda A, Martins LF, de Lima SM, et al. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study[J]. Crit Care, 2011, 15 (3): R144.
|
| 13 |
Rice TW, Wheeler AP, Thompson BT, et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury[J]. JAMA, 2011, 306 (14): 1574-1581.
|
| 14 |
Sungurtekin H, Degirmenci S, Sungurtekin U, et al. Comparison of the effects of different intravenous fat emulsions in patients with systemic inflammatory response syndrome and sepsis[J]. Nutr Clin Pract, 2011, 26 (6): 665-671.
|
| 15 |
Choudhury A, Kumar M, Sharma BC, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: relevance of 'golden window': a prospective study[J]. J Gastroenterol Hepatol, 2017, 32 (12): 1989-1997.
|
| 16 |
Mayer K, Gokorsch S, Fegbeutel C, et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis[J]. Am J Respir Crit Care Med, 2003, 167 (10): 1321-1328.
|
| 17 |
Pradelli L, Klek S, Mayer K, et al. Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis[J]. Crit Care, 2020, 24 (1): 634.
|
| 18 |
田涛，李幼生.脓毒症相关肝损害研究进展[J/CD].中华危重症医学杂志（电子版），2021，14（2）：165-167.
|
| 19 |
Hall TC, Bilku DK, Neal CP, et al. The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients[J]. Prostaglandins Leukot Essent Fatty Acids, 2016 (112): 1-11.
|
| 20 |
Donoghue V, Schleicher GK, Spruyt MGL, et al. Four-oil intravenous lipid emulsion effect on plasma fatty acid composition, inflammatory markers and clinical outcomes in acutely ill patients: a randomised control trial (Foil fact)[J]. Clin Nutr, 2019, 38 (6): 2583-2591.
|
| 21 |
Schwarzkopf KA, Queck A, Thomas D, et al. Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation[J]. PLoS One, 2019 14 (1): e0211537.
|
| 22 |
Kulkarni AV, Anand L, Vyas AK, et al. Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: an open-label randomized controlled trial[J]. J Gastroenterol Hepatol, 2021, 36 (7): 1953-1961.
|